Humenne, Slovakia

Radovan Buffa

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Radovan Buffa: Innovator in Antimicrobial Compositions

Introduction

Radovan Buffa is a notable inventor based in Humenne, Slovakia. He has made significant contributions to the field of antimicrobial compositions, holding a total of 9 patents. His work focuses on innovative solutions that leverage the properties of hyaluronic acid and its derivatives.

Latest Patents

Among his latest patents, Buffa has developed a composition comprising an iodide and a derivative of hyaluronic acid with an oxidative effect. This antimicrobial composition includes a chloramid of hyaluronic acid or modified hyaluronic acid, which features an amidic group. The hydrogens of this amidic group are substituted by chlorine atoms, enhancing its antimicrobial properties. Another significant patent involves a chlorinated derivative of hyaluronic acid, which also demonstrates a high degree of substitution by chlorine, ranging from 50% to 100%. These innovations highlight Buffa's commitment to advancing antimicrobial solutions.

Career Highlights

Throughout his career, Radovan Buffa has worked with prominent companies such as Contipro A.s. and Contipro Pharma A.s. His experience in these organizations has allowed him to refine his expertise in the development of innovative compositions.

Collaborations

Buffa has collaborated with notable colleagues, including Vladimir Velebny and Ivana Basarabova. These partnerships have contributed to the success of his projects and the advancement of his research.

Conclusion

Radovan Buffa's contributions to the field of antimicrobial compositions demonstrate his innovative spirit and dedication to improving health solutions. His patents reflect a deep understanding of chemical properties and their applications in real-world scenarios.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…